A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212

NCT07093697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bronchitis

Interventions

DRUG: DW5121
DRUG: DW51211
DRUG: DW51212

Sponsor

Daewon Pharmaceutical Co., Ltd.